EBS Summit 2016
Date
Event Type
Organiser type
Section
Event Location
Event Description
Business, policy makers and civil society must complement one another in a vision for a better future. EBS is the place where this can be made possible through constructive debate and co-operation. The EU is facing wide-scale challenges from modern migration issues to the green climate debate. On both a socio-economic and political level, the EU is in need of a fresh source of acceleration to help create solutions. Now, more than ever, key topics that must be addressed are: the European Single Market, a genuine Economic and Monetary Union, an ambitious Digital policy and the support of Entrepreneurship and Creativity throughout Europe. The effective union of business and politics is paramount to the progress of the EU, together they are able to make the bold moves required in this time of wide scale challenges.
EBS 2016: TOGETHER FOR A BETTER FUTURE
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- What ‘deal’ the EU can offer Trump
- COP29 outcome: EU upbeat on finance, disappointed on climate action
- Hard right’s Simion in with a chance as Romanians vote for president
- Developing nations blast $300 billion COP29 climate deal as insufficient
- Warsaw Mayor runs for Polish president as ruling party’s candidate